Detalles de la búsqueda
1.
Observational study to predict the efficacy and optimal duration of nivolumab treatment in patients with previously treated advanced or recurrent non-small cell lung cancer.
Jpn J Clin Oncol;
53(2): 153-160, 2023 Jan 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-36300307
2.
Final report on plasma ctDNA T790M monitoring during EGFR-TKI treatment in patients with EGFR mutant non-small cell lung cancer (JP-CLEAR trial).
Jpn J Clin Oncol;
52(7): 791-794, 2022 07 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35323965
3.
A phase II study of first-line afatinib for patients aged ≥75 years with EGFR mutation-positive advanced non-small cell lung cancer: North East Japan Study Group trial NEJ027.
BMC Cancer;
21(1): 208, 2021 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33648453
4.
Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naïve squamous cell carcinoma: North Japan lung cancer study group 1302.
Int J Clin Oncol;
26(3): 515-522, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33184754
5.
Clinical Features of Patients with an Epidermal Growth Factor Receptor T790M Mutation Detected in Circulating Tumor DNA.
Oncology;
98(1): 23-28, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-31494653
6.
Plasma ctDNA monitoring during epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor treatment in patients with EGFR-mutant non-small cell lung cancer (JP-CLEAR trial).
Jpn J Clin Oncol;
49(6): 554-558, 2019 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30809659
7.
Effect of sequential chemoradiotherapy in patients with limited-disease small-cell lung cancer who were ineligible for concurrent therapy: a retrospective study at two institutions.
Jpn J Clin Oncol;
48(1): 82-88, 2018 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29136177
8.
The clinical features of squamous cell lung carcinoma with sensitive EGFR mutations.
Int J Clin Oncol;
23(3): 452-457, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29446042
9.
Phase II Study of Modified Carboplatin Plus Weekly Nab-Paclitaxel in Elderly Patients with Non-Small Cell Lung Cancer: North Japan Lung Cancer Study Group Trial 1301.
Oncologist;
22(6): 640-e59, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28526722
10.
Randomized phase II trial comparing carboplatin plus weekly paclitaxel and docetaxel alone in elderly patients with advanced non-small cell lung cancer: north japan lung cancer group trial 0801.
Oncologist;
19(4): 352-3, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24682465
11.
Identification of age-dependent features of human bronchi using explainable artificial intelligence.
ERJ Open Res;
9(5)2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37850217
12.
Phase II trial of daily S-1 combined with weekly irinotecan in previously treated patients with advanced or recurrent squamous cell lung cancer: North Japan lung cancer group 1101.
Thorac Cancer;
14(27): 2804-2810, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37589158
13.
Primary Pleural Angiosarcoma Treated with Nivolumab and Ipilimumab: A Case Report.
Case Rep Oncol;
16(1): 75-81, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36820215
14.
Successful control of intestinal bleeding from metastasis of pulmonary pleomorphic carcinoma with pembrolizumab: A case report.
Medicine (Baltimore);
101(42): e31220, 2022 Oct 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-36281091
15.
Autoimmune pulmonary alveolar proteinosis with features similar to nonspecific interstitial pneumonia.
Respir Med Case Rep;
36: 101591, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35535320
16.
Multiple Cranial Neuropathies Similar to Orbital Apex Syndrome Associated with Pembrolizumab: A Case Report.
Case Rep Oncol;
15(3): 868-873, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36825096
17.
Efficacy and safety of first-line osimertinib treatment and postprogression patterns of care in patients with epidermal growth factor receptor activating mutation-positive advanced non-small cell lung cancer (Reiwa study): study protocol of a multicentre, real-world observational study.
BMJ Open;
12(1): e046451, 2022 Jan 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34983748
18.
The efficacy profiles of concurrent chemoradiotherapy with intensity-modulated radiotherapy followed by durvalumab in patients with unresectable stage III non-small cell lung cancer: A multicenter retrospective cohort study.
Clin Transl Radiat Oncol;
37: 57-63, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36065360
19.
Interstitial lung disease during chemotherapy combined with oxaliplatin and/or bevacizumab in advanced colorectal cancer patients.
Jpn J Clin Oncol;
41(4): 498-502, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21303791
20.
The prevalence of pulmonary fibrosis combined with emphysema in patients with lung cancer.
Respirology;
16(2): 326-31, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21114711